CARDINAL HEALTH — Exemestane Importer Profile
Pharmaceutical Importer · #1 buyer for Exemestane · $908.6K import value · 20 shipments · UNITED STATES · DGFT Verified
CARDINAL HEALTH is the #1 importer of Exemestane from India with $908.6K in import value and 20 verified shipments. CARDINAL HEALTH holds a 5.5% market share in Exemestane imports based in UNITED STATES. The company sources from 1 verified supplier across 13 formulations shipped to 1 country. Overall, CARDINAL HEALTH imports 5 pharmaceutical products worth $10.0M across 4 therapeutic categories.
CARDINAL HEALTH — Exemestane Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Exemestane to CARDINAL HEALTH?
Verified from 20 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED | $908.6K | 20 | 100.0% |
CARDINAL HEALTH sources Exemestane from 1 verified Indian supplier based on 20 customs records. The primary supplier is MSN LABORATORIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does CARDINAL HEALTH Compare to Nearest Exemestane Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CARDINAL HEALTH ★ | UNITED STATES | $800.0K | 16 | $50.0K |
| 3 | BROCACEF NL HUB | NETHERLANDS | $699.9K | 20 | $35.0K |
| 4 | FIEGE HEALTHCARE LOGISTICS GMBH | GERMANY | $604.5K | 19 | $31.8K |
CARDINAL HEALTH ranks #1 among 196 Exemestane importers from India. Average shipment value of $50.0K compared to the market average of $26.2K. The closest competitors by value are BROCACEF NL HUB and FIEGE HEALTHCARE LOGISTICS GMBH.
Where Does CARDINAL HEALTH Import Exemestane To?
Destination countries from 20 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $908.6K | 20 | 100.0% |
CARDINAL HEALTH imports Exemestane to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $908.6K.
What Exemestane Formulations Does CARDINAL HEALTH Import?
| Formulation | Value | Shipments |
|---|---|---|
| EXEMESTANE TABLETS 25 MG 90'S | $265.4K | 6 |
| EXEMESTANE 25MG 90S COUNT MEDIKL NDC NO51991-005-90 | $150.0K | 3 |
| EXEMESTANE 25MG 90S(5928 NO'S)-AS PER IN | $50.0K | 1 |
| EXEMESTANE 25MG 90S (5904 NO'S)-AS PER I | $50.0K | 1 |
| EXEMESTANE TABLETS 25 MG 90'S(5851 BOTTL | $50.0K | 1 |
| EXEMESTANE TABLETS 25 MG 90'S(5781 BOTTL | $50.0K | 1 |
| EXEMESTANE TABLETS 25 MG 90'S(5760 BOTTL | $50.0K | 1 |
| EXEMESTANE 25MG 90S COUNT MEDIKL NDC NO: 51991-005-90 (5736 BOTTLES, PER BOTTEL90 COUNTS) | $50.0K | 1 |
| Exemestane 25mg 90scount Medikl NDC NO :51991-005-90 (5760 X 90S PACKS=518400 TABLETS) | $50.0K | 1 |
| EXEMESTANE 25MG 90S (3048 NO'S)-AS PER I | $43.3K | 1 |
CARDINAL HEALTH imports 13 distinct Exemestane formulations from India. The top formulation is EXEMESTANE TABLETS 25 MG 90'S with 6 shipments worth $265.4K.
Regulatory Requirements: Importing Exemestane into United States
What CARDINAL HEALTH and other importers must comply with to import Exemestane from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Exemestane
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Exemestane from India and How Much Does CARDINAL HEALTH Import?
India exported $5.1M worth of Exemestane through 1,533 shipments from 87 suppliers to 57 countries, serving 196 buyers globally. CARDINAL HEALTH imports $908.6K of this total, accounting for 5.5% of India's Exemestane exports with 20 shipments from UNITED STATES. This is verified from 20 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for CARDINAL HEALTH's Exemestane Imports?
CARDINAL HEALTH's average Exemestane order value is $45.4K per consignment, based on 20 shipments totaling $908.6K. CARDINAL HEALTH is based in UNITED STATES and ranks #1 among all Exemestane importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Exemestane to CARDINAL HEALTH?
CARDINAL HEALTH sources Exemestane from 1 verified Indian supplier: MSN LABORATORIES PRIVATE LIMITED ($908.6K, 100.0%). This is based on 20 customs records.
How Does CARDINAL HEALTH Compare to Other Exemestane Importers?
CARDINAL HEALTH ranks #1 among 196 Exemestane importers from India with a 5.5% market share. The top 3 importers are CARDINAL HEALTH ($800.0K), BROCACEF NL HUB ($699.9K), FIEGE HEALTHCARE LOGISTICS GMBH ($604.5K). CARDINAL HEALTH processed 20 shipments from UNITED STATES.
About CARDINAL HEALTH
CARDINAL HEALTH imports 5 products worth $10.0M. Beyond Exemestane, top products include Clindamycin, Diclofenac, Tetracycline, Alprazolam. View the complete CARDINAL HEALTH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Exemestane — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Exemestane shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CARDINAL HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CARDINAL HEALTH's capped import value divided by total capped export value for Exemestane across all Indian exporters.
- 5.Verified Records: This page is backed by 20 individual customs records matching CARDINAL HEALTH importing Exemestane, covering 13 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 57+ countries, 196+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Exemestane Import Data for CARDINAL HEALTH
Access order-level details, pricing data, supplier connections, and competitive analysis for CARDINAL HEALTH's Exemestane imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CARDINAL HEALTH
Full Company Profile →
5 products · $10.0M total trade · 4 categories
CARDINAL HEALTH × Exemestane
Verified from customs records
Company Overview
Top Products by CARDINAL HEALTH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CARDINAL HEALTH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Exemestane. For current order-level data, contact TransData Nexus.